(Q40638840)

English

A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines

scientific article published on September 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Emmanuel Richard

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Fabien Géronimi

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Magalie Lalanne

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Cécile Ged

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Isabelle Redonnet-Vernhet

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Isabelle Lamrissi-Garcia

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Stanton L Gerson

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Hubert de Verneuil

8

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

François Moreau-Gaudry

9

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Journal of Gene Medicine

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

737-747

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Correction of sickle cell disease in transgenic mouse models by gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

In vivo selection of retrovirally transduced hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

G156A MGMT-transduced human mesenchymal stem cells can be selectively enriched by O6-benzylguanine and BCNU.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Lentiviral vectors for enhanced gene expression in human hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

HIV-1 genome nuclear import is mediated by a central DNA flap

1 reference

https://api.crossref.org/works/10.1002%2FJGM.407

21 January 2018

Identifiers

10.1002/JGM.407

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40638840&oldid=1904045587"